Cybin (HELP) Long-Term Debt Issuances (2020 - 2025)

Cybin (HELP) posted quarterly Long-Term Debt Issuances of $44.5 million for Q2 2025, up 20467.46% on a QoQ basis from $216361.2 in Q2 2020.

Cybin (HELP) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

Cybin (HELP) has reported Long-Term Debt Issuances for 2 consecutive years, with $44.5 million the latest figure, recorded in Q2 2025.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $44.5 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $44.5 million (changed N/A YoY) and the FY2026 annual result came in at $44.5 million, changed N/A from the prior year.
Long-Term Debt Issuances improved to $44.5 million in Q2 2025 per HELP's latest filing, from $216361.2 in the prior quarter.
Over the last five years, Long-Term Debt Issuances for HELP reached as high as $44.5 million in Q2 2025 and fell as low as $44.5 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Cybin	28.04 Mn	28.04 Mn	-	-

Download Data